Immune modulation in gene therapy studies
Points to consider for Environmental Risk Assessment
Summary Host immune responses play a major role in clearance of viral infections from the body, and may limit long-term expression and clinical efficacy of viral vectors. Methods to prevent these immune responses may also increase the risk for infections, recombination with wild type virus and affect biodistribution, persistence, shedding and transmission. The study described in this report was initiated to assess possible environmental risks associated with the use of immune modulation in combination with gene therapy and set up as a literature study, by performing PubMed searches for certain keywords, by interviewing experts and by attending selected meetings. Lack of availability of clinical data combining gene therapy and immune modulation and limited animal data warranted additional exploration of relevant non-gene therapy studies from closely related fields such as stem cell and organ transplantation, and vaccination studies with live attenuated vaccines.<br/> ......<br/> Finally, we propose the use of a checklist to assess current environmental risks in the use of immune modulation during gene therapy. This report is expected to provide guidance to risk assessors and regulatory officers as well as to applicants for a gene therapy licence.
|Environmental Risks, Gene Therapy, Immune Modulation, Viral Vector|
|Erasmus MC: University Medical Center Rotterdam|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Aerts Kaya, F.S.F, Kaptein, L.C.M, & Wagemaker, G. (2010). Immune modulation in gene therapy studies. Erasmus MC: University Medical Center Rotterdam. Retrieved from http://hdl.handle.net/1765/21967